Improvement of the myocardial performance index in atrial fibrilation patients treated with amiodarone after cardioversion

dc.contributor.authorBeşli, Feyzullah
dc.contributor.authorBaşar, Cengiz
dc.contributor.authorKeçebaş, Mesut
dc.contributor.authorTürker, Yasin
dc.date.accessioned2020-04-30T23:18:26Z
dc.date.available2020-04-30T23:18:26Z
dc.date.issued2015
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionWOS: 000350824500006en_US
dc.descriptionPubMed: 25591725en_US
dc.description.abstractThis study evaluated the response to electrical cardioversion (EC) and the effect on the myocardial performance index (MPI) in patients with persistent and long-standing persistent atrial fibrillation (AF). We enrolled 103 patients (mean age 69.6 +/- 8.9 years, 40.7 % males) with a diagnosis of persistent and long-standing persistent AF. EC was applied to all patients after one g of amiodarone administration. Echocardiographic findings before EC were compared in patients with successful versus unsuccessful cardioversions and in patients with maintained sinus rhythm (SR) versus those with AF recurrence at the end of the first month. We also compared echocardiographic data before EC versus at the end of the first month in the same patients with maintained SR. SR was achieved in 72.8 % of patients and was continued at the end of the first month in 69.3 % of the patients. The MPI value of all patients was found to be 0.73 +/- 0.21. The size of the left atrium was determined to be an independent predictor of the maintenance of SR at 1 month. In subgroup analyses, when we compared echocardiographic findings before EC and at the end of the first month in patients with maintained SR, the MPI (0.66 +/- 0.14 vs 0.56 +/- 0.09, p < 0.001) values were significantly decreased. Our study is the first to show impairment of the MPI, which is an indicator of systolic and diastolic function, in patients with persistent and long-standing persistent AF and improvement of the MPI after successful EC.en_US
dc.identifier.doi10.1007/s10840-014-9965-0en_US
dc.identifier.endpage115en_US
dc.identifier.issn1383-875X
dc.identifier.issn1572-8595
dc.identifier.issue2en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage107en_US
dc.identifier.urihttps://doi.org/10.1007/s10840-014-9965-0
dc.identifier.urihttps://hdl.handle.net/20.500.12684/3310
dc.identifier.volume42en_US
dc.identifier.wosWOS:000350824500006en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofJournal Of Interventional Cardiac Electrophysiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAtrial fibrillationen_US
dc.subjectMyocardial performance indexen_US
dc.subjectElectrical cardioversionen_US
dc.titleImprovement of the myocardial performance index in atrial fibrilation patients treated with amiodarone after cardioversionen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
3310.pdf
Boyut:
1.44 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text